SCHEMBL1968781

SCHEMBL1968781

Brc1cc(Cn2cc(-c3cncc(-c4nnn[nH]4)c3)nn2)cc(Br)c1Br

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SCD O00767 3/20 0.56
ROCK2 O75116 4/20 0.38
GSK3B P49841 4/20 0.38
PIM1 P11309 3/20 0.38
AURKB Q96GD4 3/20 0.38
TEK Q02763 7/20 0.37
EPHB4 P54760 3/20 0.37
KDR P35968 6/20 0.37
PLK4 O00444 1/20 0.36
AURKA O14965 1/20 0.36
CHUK O15111 1/20 0.36
MAPK13 O15264 1/20 0.36
DAPK3 O43293 1/20 0.36
JAK2 O60674 1/20 0.36
CHEK2 O96017 1/20 0.36
PRKCG P05129 1/20 0.36
CDK1 P06493 1/20 0.36
FGFR1 P11362 1/20 0.36
PRKACA P17612 1/20 0.36
RPS6KB1 P23443 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1969076 0.76 SCD (0.56) SCDTEKEPHB4KDRCYP19A1
SCHEMBL1986566 0.72 SCD (1.00) SCD
SCHEMBL1968014 0.69 SCD (0.70) SCDMAPK1
SCHEMBL762270 0.66 PTK2 (0.50) DYRK1A
SCHEMBL22557790 0.64 CYP19A1 (0.49) ROCK2GSK3BPIM1AURKBTEK
SCHEMBL1969887 0.62 GSK3B (0.36) ROCK2GSK3BPIM1AURKBKDR
SCHEMBL16619899 0.62 PRMT6 (0.40) GSK3BKDRCDK1DYRK1A
SCHEMBL30837618 0.61 METTL3 (0.47) SCDROCK2GSK3BPIM1AURKB
SCHEMBL1967914 0.61 SCD (0.57) SCDCYP19A1
SCHEMBL12352749 0.60 CYP2A6 (0.42)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152295-A1 HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2011-06-23 US disclosed
EP-2334666-A1 HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE Merck Canada Inc. (CA) 2011-06-22 EP disclosed
WO-2010025553-A1 HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE MERCK FROSST CANADA LTD. (CA) 2010-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152295-A1 HETEROAROMATIC COMPOUNDS AS INHIBITORS OF STEAROYL-COENZYME A DELTA-9 DESATURASE SCD, SCD5, SREBF1 SCD 1/4885ROCK2 3808/4885GSK3B 539/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.